Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

GSK and Dr. Reddy’s Agree To Product Development And Marketing Alliance

By Pharmaceutical Processing | June 15, 2009

LONDON — GlaxoSmithKline PLC said Monday it had reached a deal with Indian drug developer Dr. Reddy’s Laboratories Ltd. to develop and market selected products across many emerging markets. London-based Glaxo did not reveal terms of the deal, which is effective immediately but excludes India. Under the agreement, Glaxo will gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management. The products will be manufactured by Dr. Reddy’s and licensed and supplied by Glaxo in various countries in Africa, the Middle East, Asia Pacific and Latin America. In some markets, products will be co-marketed by Glaxo and Dr. Reddy’s. Revenues will be reported by Glaxo, and shared with Dr. Reddy’s, Glaxo said. “This is another significant step forward in our strategy to grow and diversify GSK’s business in emerging markets,” said Abbas Hussain, president for emerging markets at GlaxoSmithKline. “Growth in both population and economic prosperity is leading to increased demand for branded pharmaceuticals.”

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE